Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $100000.0.

  • Milestone Scientific's Cash from Operations rose 11026.78% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 5985.81%. This contributed to the annual value of -$2.9 million for FY2024, which is 4517.83% up from last year.
  • As of Q3 2025, Milestone Scientific's Cash from Operations stood at $100000.0, which was up 11026.78% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's Cash from Operations ranged from a high of $783655.0 in Q2 2024 and a low of -$2.3 million during Q2 2022
  • Over the past 5 years, Milestone Scientific's median Cash from Operations value was -$1.1 million (recorded in 2021), while the average stood at -$1.1 million.
  • Per our database at Business Quant, Milestone Scientific's Cash from Operations soared by 17656.34% in 2024 and then tumbled by 32866.07% in 2025.
  • Quarter analysis of 5 years shows Milestone Scientific's Cash from Operations stood at -$404639.0 in 2021, then tumbled by 169.29% to -$1.1 million in 2022, then dropped by 12.53% to -$1.2 million in 2023, then dropped by 23.27% to -$1.5 million in 2024, then soared by 106.62% to $100000.0 in 2025.
  • Its Cash from Operations stands at $100000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.0 million for Q1 2025.